Ellen H. Nagami

551 total citations
11 papers, 283 citations indexed

About

Ellen H. Nagami is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ellen H. Nagami has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Ellen H. Nagami's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Ellen H. Nagami is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Ellen H. Nagami collaborates with scholars based in United States and Germany. Ellen H. Nagami's co-authors include Barbara McGovern, Christopher Birch, Raymond T. Chung, Laura L. Reyor, Arthur Y. Kim, Georg M. Lauer, Miriam B. Barshak, David C. Hooper, Boris Jülg and Elizabeth Hohmann and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Ellen H. Nagami

11 papers receiving 280 citations

Peers

Ellen H. Nagami

EPIDE

HEPAT

VIROL

IMMUN

Sandra Scherbeijn Netherlands

Melanie R. Walker Australia

Giuseppina Cappiello Italy

Gaëtan Ligat France

Adrian Hill United Kingdom

Nina G. Barzaga Philippines

Daitze Wu China

Christine A. Bellezza United States

Yi‐Ming Arthur Chen Taiwan

Senthil Chinnakannan United Kingdom

Sandra Scherbeijn Netherlands

Ellen H. Nagami

234 ×1.3

EPIDE

116 ×0.9

HEPAT

156 ×1.5

VIROL

122 ×2.1

41 ×0.8

IMMUN

Citations per year, relative to Ellen H. Nagami Ellen H. Nagami (= 1×) peers Sandra Scherbeijn

Countries citing papers authored by Ellen H. Nagami

Since Specialization

Citations

This map shows the geographic impact of Ellen H. Nagami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen H. Nagami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen H. Nagami more than expected).

Fields of papers citing papers by Ellen H. Nagami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen H. Nagami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen H. Nagami. The network helps show where Ellen H. Nagami may publish in the future.

Co-authorship network of co-authors of Ellen H. Nagami

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen H. Nagami. A scholar is included among the top collaborators of Ellen H. Nagami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen H. Nagami. Ellen H. Nagami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Rogers, Ralph, et al.. (2022). Broad Antimicrobial Resistance in a Case of Relapsing Babesiosis Successfully Treated With Tafenoquine. Clinical Infectious Diseases. 76(4). 741–744. 16 indexed citations

Matias, Wilfredo R., Ellen H. Nagami, Erica S. Shenoy, et al.. (2022). Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States. Open Forum Infectious Diseases. 9(8). ofac377–ofac377. 69 indexed citations

Nagami, Ellen H., Kinna Thakarar, & Paul E. Sax. (2021). Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance. Open Forum Infectious Diseases. 9(2). ofab648–ofab648. 1 indexed citations

Nagami, Ellen H., et al.. (2017). Experience of Treating Patients With Multidrug-Resistant Tuberculosis at a Public Health Hospital in Boston. Infectious Diseases in Clinical Practice. 25(6). 314–319. 1 indexed citations

Onofrey, Shauna, Jasneet Aneja, Gillian Haney, et al.. (2015). Underascertainment of Acute Hepatitis C Virus Infections in the U.S. Surveillance System. Annals of Internal Medicine. 163(4). 254–261. 26 indexed citations

Nagami, Ellen H., Arthur Y. Kim, Rachel Baden, & Barbara McGovern. (2013). Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient.. PubMed. 20(4). 134–8. 1 indexed citations

Kim, Arthur Y., et al.. (2012). A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Hepatology. 57(3). 944–952. 25 indexed citations

Nagami, Ellen H., et al.. (2010). A "One-Two Punch" Leading to Hepatitis C Seroconversion. Clinical Infectious Diseases. 52(3). 361–363. 4 indexed citations

Nolting, Anne, Anne‐Sophie Dugast, Suzannah J. Rihn, et al.. (2010). MHC class I chain-related protein A shedding in chronic HIV-1 infection is associated with profound NK cell dysfunction. Virology. 406(1). 12–20. 44 indexed citations

10.

McGovern, Barbara, Ellen H. Nagami, Christopher Birch, et al.. (2009). Rate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV Infection. The Journal of Infectious Diseases. 200(6). 877–881. 17 indexed citations

11.

McGovern, Barbara, et al.. (2009). Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria. Clinical Infectious Diseases. 49(7). 1051–1060. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact